Pseudomyxoma peritonei: A review of 62 cases

European Journal of Surgical Oncology

Volumn 29, Issue 8, 2003, Pages 682-688

  van Ruth, S ^a   Acherman, Y I Z ^a   van de Vijver, M J ^a   Hart, A A M ^a   Verwaal, V J ^a   Zoetmulder, F A N ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Disseminated peritoneal adenomucinosis; HIPEC; Pathology; Peritoneal mucinous carcinomatosis with intermediate or discordant features; Pseudomyxoma peritonei

Indexed keywords

FLUOROURACIL; FOLINIC ACID; MITOMYCIN C;

ABDOMEN; ADULT; AGED; APPENDIX; CANCER CHEMOTHERAPY; CANCER SURGERY; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTHERMIC THERAPY; MAJOR CLINICAL STUDY; MALE; MUCOSA; MUCUS; OVARY TUMOR; PERITONEUM PSEUDOMYXOMA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; STATISTICAL ANALYSIS; SURVIVAL RATE; TUMOR GROWTH;

EID: 0141954881     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(03)00149-5     Document Type: Article

References (26)

1. van de Vaart PJ, van der Vange N, Zoetmulder FA et al. Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell lines. Eur J Cancer 1998; 34: 148-54.
2. Katano K, Tsujitani S, Oka S et al. Pharmacokinetics of hypotonic cisplatin chemotherapy administered into the peritoneal and the pleural cavities in experimental model. Anticancer Res 2000; 20: 1603-7.
3. Rusch VW, Venkatraman ES. Important prognostic factors in patients with malignant pleural mesothelioma. Managed surgically. Ann Thorac Surg 1999; 68: 1799-804.
4. Sherer DM, Abulafia O, Eliakim R. Pseudomyxoma peritonei: a review of current literature. Gynecol Obstet Invest 2001; 51: 73-80.
5. Jacquet P, Averbach A, Stuart OA, Chang D, Sugarbaker PH. Hyperthermic intraperitoneal doxorubicin: pharmacokinetics, metabolism, and tissue distribution in a rat model. Cancer Chemother Pharmacol 1998; 41: 147-54.
6. Mets T, Van Hove W, Louis H. Pseudomyxoma peritonei. report of a case with extraperitoneal metastasis and invasion of the spleen. Chest 1977; 72: 792-4.
7. Chevillotte G, Choux R, Spik G et al. [Pseudomyxoma peritonei: a case with multiple metastases. Ultrastructural study and chemical analysis of the mucoid substance] Pseudomyxome peritoneal: un cas avec metastases multiples. Etude ultrastructurale et analyse chimique de la substance mucoide. Gastroenterol Clin Biol 1983; 7: 445-50.
8. Kreissig P, Daucourt J, Garnier G. [Pseudomyxoma peritonei with pulmonary metastasis] Maladie gelatineuse du peritoine avec metastases pulmonaires. Presse Med 1991; 20: 1287.
9. Radosavljevic G, Nedeljkovic B, Kacar V. Pseudomyxoma of the pleural and peritoneal cavities. Thorax 1993; 48: 94-5.
10. Rusch VW, Niedzwiecki D, Tao Y et al. Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies. J Clin Oncol 1992; 10: 1001-6.
11. Ronnett BM, Kurman RJ, Zahn CM et al. Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Hum Pathol 1995; 26: 509-24.
12. Yasumoto K, Shimokawa T, Nagashima A, Hirose N, Nakahashi H. Pharmacokinetics of cisplatin instilled into the pleural cavity following panpleuropneumonectomy in patients with malignant pleurisy due to lung cancer. J Surg Oncol 1993; 54: 67-70.
13. Young RH, Gilks CB, Scully RE. Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei. A clinicopathological analysis of 22 cases supporting an origin in the appendix. Am J Surg Pathol 1991; 15: 415-29.
14. Prayson RA, Hart WR, Petras RE. Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors. Am J Surg Pathol 1994; 18: 591-603.
15. Kurita M, Komatsu H, Hata Y et al. Pseudomyxoma peritonei due to adenocarcinoma of the lung: case report. J Gastroenterol 1994; 29: 344-8.
16. McCarthy JH, Aga R. A fallopian tube lesion of borderline malignancy associated with pseudo-myxoma peritonei. Histopathology 1988; 13: 223-5.
17. de Bree E, Witkamp A, Van De Vijver M, Zoetmulder F. Unusual origins of pseudomyxoma peritonei. J Surg Oncol 2000; 75: 270-4.
18. Ronnett BM, Yan H, Kurman RJ, Shmookler BM, Wu L, Sugarbaker PH. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer 2001; 92: 85-91.
19. Hinson FL, Ambrose NS. Pseudomyxoma peritonei. Br J Surg 1998; 85: 1332-9.
20. Sugarbaker PH. Cytoreductive surgery and perioperative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Tumori 2001; 87: S3-S5.
21. Witkamp AJ, de Bree E, Kaag MM, van Slooten GW, van Coevorden F, Zoetmulder FA. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Br J Surg 2001; 88: 458-63.
22. Wientjes MG, Badalament RA, Wang RC, Hassan F, Au JL. Penetration of mitomycin C in human bladder. Cancer Res 1993; 53: 3314-20.
23. Markman M. Intraperitoneal chemotherapy. Semin Oncol 1991; 18: 248-54.
24. Szych C, Staebler A, Connolly DC, Wu R, Cho KR, Ronnett BM. Molecular genetic evidence supporting the clonality and appendiceal origin of pseudomyxoma peritonei in women. Am J Pathol 1999; 154: 1849-55.
25. Witkamp AJ, de Bree E, Kaag MM et al. Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur J Cancer 2001; 37: 979-84.
26. Elias D, Blot F, El Otmany A et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001; 92: 71-6.